Lim H, Devesa SS, Sosa JA et al (2017) Trends in thyroid cancer incidence and mortality in the United States, 1974–2013. JAMA 317:1338–1348

Article  PubMed  PubMed Central  Google Scholar 

Lorusso L, Minaldi E, Esposito G et al (2023) Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features. J Endocrinol Invest 46:2165–2173

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dadu R, Cabanillas ME (2012) Optimizing therapy for radioactive iodine-refractory differentiated thyroid cancer: Current state of the art and future directions. Minerva Endocrinol 37:335–356

CAS  PubMed  PubMed Central  Google Scholar 

Brose MS, Nutting CM, Jarzab B et al (2014) Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet 384:319–328

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lodi Rizzini E, Repaci A, Tabacchi E et al (2021) Impact of 18F-FDG PET/CT on clinical management of suspected radio-iodine refractory differentiated thyroid cancer (RAI-R-DTC). Diagnostics (Basel) 11:1430

Article  CAS  PubMed  Google Scholar 

Kitahara CM, Sosa JA (2016) The changing incidence of thyroid cancer. Nat Rev Endocrinol 12:646–653

Article  PubMed  PubMed Central  Google Scholar 

Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133

Article  PubMed  PubMed Central  Google Scholar 

Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA (2004) Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 45:1519–1527

PubMed  Google Scholar 

Nakajo M, Jinguji M, Shinaji T et al (2019) 18F-FDG-PET/CT features of primary tumours for predicting the risk of recurrence in thyroid cancer after total thyroidectomy: potential usefulness of combination of the SUV-related, volumetric, and heterogeneous texture parameters. Br J Radiol 92:20180620

Article  PubMed  Google Scholar 

Huang J, Huang L, Zhou J et al (2017) Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection. Eur J Nucl Med Mol Imaging 44:1958–1968

Article  PubMed  PubMed Central  Google Scholar 

Utsunomiya T, Ogawa K, Funamizu N et al (2022) The tumor-to-liver ratio of the standardized uptake value is a useful FDG-PET/CT parameter for predicting malignant intraductal papillary mucinous neoplasm of the pancreas. Ann Gastroenterol Surg 6:695–703

Article  PubMed  PubMed Central  Google Scholar 

Fedorov A, Beichel R, Kalpathy-Cramer J et al (2012) 3D Slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging 30:1323–1341

Article  PubMed  PubMed Central  Google Scholar 

Schlumberger M, Brose M, Elisei R et al (2014) Definition and management of radioactive iodine-refractory differentiated thyroid cancer. Lancet Diabetes Endocrinol 2:356–358

Article  PubMed  Google Scholar 

Schlumberger M, Jarzab B, Cabanillas ME et al (2016) A phase II trial of the multitargeted tyrosine kinase inhibitor lenvatinib (E7080) in advanced medullary thyroid cancer. Clin Cancer Res 22:44–53

Article  CAS  PubMed  Google Scholar 

Hotta M, Gafita A, Murthy V et al (2023) PSMA PET tumor-to-salivary gland ratio to predict response to [177Lu] PSMA radioligand therapy: An international multicenter retrospective study. J Nucl Med 64:1024–1029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faubert B, Li KY, Cai L et al (2017) Lactate metabolism in human lung tumors. Cell 171:358-371.e9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piccardo A, Puntoni M, Bertagna F et al (2014) 18F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging 41:1482–1491

Article  CAS  PubMed  Google Scholar 

Markantes GK, Karakioulaki M, Papanikolopoulou S et al (2021) Improving the prediction of persistent and recurrent differentiated thyroid cancer using the American Thyroid Association 2015 risk stratification system. Hormones (Athens) 20:761–768

Article  PubMed  Google Scholar 

Kumar V, Nath K, Berman CG et al (2013) Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings. Clin Nucl Med 38:175–182

Article  PubMed  PubMed Central  Google Scholar 

Lin P, Min M, Lee M et al (2017) Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers. Eur J Nucl Med Mol Imaging 44(5):801–811

Article  CAS  PubMed  Google Scholar 

Manohar PM, Beesley LJ, Bellile EL et al (2018) Prognostic value of FDG-PET/CT metabolic parameters in metastatic radioiodine-refractory differentiated thyroid cancer. Clin Nucl Med 43:641–647

Article  PubMed  PubMed Central  Google Scholar 

Wu M, Ou-yang D, Wei B et al (2022) A prognostic model of differentiated thyroid cancer based on up-regulated glycolysis-related genes. Front Endocrinol 13:775278

Article  Google Scholar 

Links TP (2005) Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer 12:273–280

Article  CAS  PubMed  Google Scholar 

Li W, Xu M, Li Y et al (2020) Comprehensive analysis of the association between tumor glycolysis and immune/inflammation function in breast cancer. J Transl Med 18:92

Article  CAS  PubMed  PubMed Central  Google Scholar